Tenex Health (Lake Forest, CA) landed FDA clearance for its new TX2 MicroTip Ultrasonic Device for removal of soft tissue when treating tendi**sis of the Shoulder or hip. Percutaneous te**tomies can be performed in an outpatient setting with the device, which is a longer version of the TX1 MicroTip.
The original generation of the Device has a tip that’s too short for Shoulder and hip procedures. The new Device has a two inch tip which allows for a wider range of te**tomies to be performed with Tenex’s tech**logy.
“The TX1 MicroTip has enjoyed tremendous clinical success in treating over 35,000 patients in the US since its introduction in 2012,” said Dr. Bernard Morrey, Chief Medical ******r of Tenex Health. “Of these patients, only a small portion have been treated with Shoulder or hip tendi**sis due to the inaccessibility of the deeper tissues to the TX1 MicroTip. The length and design of the TX2 MicroTip is well poised to effectively treat a large number of patients with a spectrum of conditions in these anatomic areas. We anticipate providing a favorable safety and efficacy profile to a broader group of patients using this ultrasound guided treatment.”
03-30-2016, 09:10 PM
Tenex TX2 MicroTip Ultrasonic Surgical Device for Tende**sis in Hip, Shoulder
العرض الشجري